tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market

Keros Therapeutics (KROS) Revenue

Compare
332 Followers

Keros Therapeutics Revenue

Keros Therapeutics had a revenue of 3.04M in the quarter ending Dec 31, 2024, with 684.02%. This bring the company's revenue in the last twelve months to 3.55M, Decreased 445.31%. In the fiscal year ending Dec 31, 2024, Keros Therapeutics had annual revenue of 3.55M with 2250.99% growth.
Revenue (ttm)
3.55M
Revenue Growth
2250.99%
P/S Ratio
139.17
Revenue/Employee
$21,006
Employees
169
Market Cap
$494.05M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 20243.55M3.40M+2,250.99%
Dec 31, 2023151.00K+∞%
Dec 31, 20220.00-20.10M-100.00%
Dec 31, 202120.10M+∞%
Dec 31, 20200.00-10.00M-100.00%
Dec 31, 201910.00M0.000.00%
Dec 31, 201810.00M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis